ArticleBMC cancer2024

The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study.

Lan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.